Many women navigating midlife and menopause seek various approaches to manage their symptoms. This can sometimes involve using dietary supplements like Evening Primrose Oil (EPO) alongside over-the-counter medications such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
Understanding how these might interact is a common and important consideration. This article aims to provide information on what is currently understood about combining EPO with NSAIDs, emphasizing that current evidence is limited.
What is Evening Primrose Oil (EPO)?
Evening Primrose Oil is derived from the seeds of the evening primrose plant (Oenothera biennis). It is a source of gamma-linolenic acid (GLA), an omega-6 fatty acid. GLA is converted in the body into substances that may play a role in various bodily functions.
For women in midlife and menopause, EPO is sometimes considered for supporting comfort related to breast tenderness, hot flashes, and skin dryness. It’s often chosen as a complementary approach rather than a primary solution.
Understanding NSAIDs
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are a class of medications commonly used to help manage pain, reduce inflammation, and lower fever. Familiar examples include ibuprofen, naproxen, and aspirin (at higher doses).
NSAIDs work by affecting specific enzymes in the body that are involved in the production of prostaglandins, which are compounds that contribute to inflammation and pain. They are widely available and frequently used for common discomforts like headaches, muscle aches, and menstrual cramps.
Exploring the Evening Primrose Oil NSAID Interaction: What We Know
When considering the combined use of Evening Primrose Oil and NSAIDs, it’s natural to wonder about potential interactions. Both substances do act on inflammatory pathways, but that is not where the interaction worth knowing about sits. The overlap that matters is on platelets, the blood cells responsible for forming clots.
Evening Primrose Oil supplies gamma-linolenic acid, which the body converts to dihomo-gamma-linolenic acid. That metabolite is oxidised by the enzyme 12-lipoxygenase into a compound that inhibits platelet activation and thrombus formation in laboratory and animal models, while leaving normal hemostatic measures such as bleeding time unchanged in those same experiments[1].
The effect has also been measured in people. In a randomized, NIH-funded trial, postmenopausal women who supplemented with evening primrose oil showed reduced platelet aggregation in response to thrombin receptor stimulation, reduced dense granule secretion, and lower baseline platelet integrin activation, with some of those changes still present after a washout period[2]. In rabbits, EPO lengthened every coagulation assay tested except fibrinogen time and significantly reduced platelet count[3].
Research pairing EPO directly with an NSAID does exist, although not yet in humans. Two animal studies combined EPO with celecoxib, a COX-2 selective NSAID. In rats, celecoxib raised blood pressure and accelerated clot formation, and adding EPO reduced both the blood pressure rise and platelet aggregation[4]. In mice, EPO reduced the celecoxib-driven rise in tissue factor activity and the associated clotting markers[5]. In those particular models EPO offset a clotting risk rather than compounding one, which is a useful reminder that the direction of this interaction is not simply additive.
What is genuinely missing is the study that would settle the practical question: no published trial has measured bleeding outcomes in people taking EPO alongside aspirin, ibuprofen, or naproxen. The mechanistic concern still deserves attention, because aspirin and non-selective NSAIDs reduce platelet aggregation through cyclooxygenase inhibition while EPO appears to reduce it by a separate route. A published case report describes severe thrombocytopenia in a woman who had taken evening primrose oil and black seed oil daily for about a month before surgery, with the authors naming EPO’s recognised antiplatelet properties as a contributing factor[6]. A single case cannot establish cause, but it is the sort of signal that makes this a conversation to have with a prescriber rather than a question to settle alone.
General Safety Considerations for Combined Use
Regardless of the specific interaction, it’s always prudent to consider general safety when combining any supplement with medication. Both Evening Primrose Oil and NSAIDs have their own profiles of potential effects.
For example, NSAIDs are known to potentially affect the gastrointestinal system and kidneys, particularly with long-term use or in individuals with pre-existing conditions. Evening Primrose Oil is generally considered well-tolerated, and the most commonly reported complaint is mild digestive upset. The effect specific to this combination is the one on platelets described above, so if you take daily low-dose aspirin, a prescribed antiplatelet or anticoagulant medication, or NSAIDs regularly, tell your prescriber that you are also taking EPO, and mention it ahead of any planned surgery or dental procedure.
When considering any combination, it’s important to monitor your body for any new or unusual symptoms. Keeping track of what you are taking and how you feel can help you identify any potential issues.
Navigating Supplement and Medication Use During Midlife and Menopause
The journey through midlife and menopause often involves exploring various options for symptom support. This can include dietary changes, lifestyle adjustments, supplements like EPO, and sometimes over-the-counter medications like NSAIDs.
The most informed approach involves open communication with a healthcare provider. They can help you assess your individual health profile, consider all the substances you are taking, and provide personalized advice based on your needs and any existing health conditions.
It’s always recommended to discuss all supplements and medications you are using, or considering using, with a healthcare professional to ensure a safe and supportive approach to your well-being.
References
- 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets. Arteriosclerosis, thrombosis, and vascular biology, 2016
- Supplementation with omega-3 or omega-6 fatty acids attenuates platelet reactivity in postmenopausal women. Clinical and translational science, 2022
- Assessment of anticoagulant effect of evening primrose oil. Pakistan journal of pharmaceutical sciences, 2009
- Effect of evening primrose oil and ω-3 polyunsaturated fatty acids on the cardiovascular risk of celecoxib in rats. Journal of cardiovascular pharmacology, 2011
- Evening primrose oil or forskolin ameliorates celecoxib-enhanced upregulation of tissue factor expression in mice subjected to lipopolysaccharide-induced endotoxemia. Naunyn-Schmiedeberg’s archives of pharmacology, 2017
- Severe Thrombocytopenia Associated With Black Seed Oil and Evening Primrose Oil. Cureus, 2020
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
